Incidence and Prognosis of Different Types of Functional Renal Failure in Cirrhotic Patients with Ascites
Overview
Authors
Affiliations
Background & Aims: Hepatorenal syndrome is a well-characterized type of terminal renal failure that occurs in patients with cirrhosis with ascites. Information about other types of functional renal failure in these patients is scarce. We assessed the incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites and investigated prognostic factors for these disorders.
Methods: Consecutive cirrhotic patients (n = 263) were followed for 41 +/- 3 months after their first incidence of ascites. Three types of functional renal failure were considered: pre-renal failure (when renal failure was associated with a depletion of intravascular volume), renal failure induced by infection that did not result in hepatorenal syndrome, and hepatorenal syndrome.
Results: During the follow-up period, 129 (49%) patients developed some type of functional renal failure. The most frequent was pre-renal failure (27.4%), followed by renal failure induced by infection (14.1%), and then hepatorenal syndrome (7.6%). The 1-year probability of developing the first episode of any functional renal failure was 23.6%. The independent predictors of functional renal failure development were baseline age, Child-Pugh score, and serum creatinine. Although the 1-year probability of survival was 91% in patients without renal failure, it decreased to 46.9% in those patients who developed any functional renal failure (P = .0001).
Conclusions: Approximately 50% of the cirrhotic patients with ascites developed some type of functional renal failure during the follow-up period; renal failure was associated with worse prognosis. Efforts should be made to prevent renal failure in cirrhotic patients with ascites.
Kidney Outcomes Following Utilization of Molecular Adsorbent Recirculating System.
Trautman C, Khan M, Baker L, Aslam N, Fitzpatrick P, Porter 2nd I Kidney Int Rep. 2023; 8(10):2100-2106.
PMID: 37850016 PMC: 10577361. DOI: 10.1016/j.ekir.2023.07.035.
Management of hepatorenal syndrome in liver cirrhosis: a recent update.
Bera C, Wong F Therap Adv Gastroenterol. 2022; 15:17562848221102679.
PMID: 35721838 PMC: 9201357. DOI: 10.1177/17562848221102679.
Tapper E, Zhao Z, Mazumder N, Parikh N Dig Dis Sci. 2022; 67(11):5327-5335.
PMID: 35262903 PMC: 10905652. DOI: 10.1007/s10620-022-07454-3.
Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018.
Singh J, Dahiya D, Kichloo A, Singh G, Khoshbin K, Shaka H Ann Med. 2022; 53(1):2018-2024.
PMID: 34985399 PMC: 8604523. DOI: 10.1080/07853890.2021.1998595.
Lee D, Fan G, Hastie D, Prakasam V, Addonizio E, Ahern R J Clin Exp Hepatol. 2021; 11(5):531-543.
PMID: 34511813 PMC: 8414330. DOI: 10.1016/j.jceh.2021.01.005.